BDX Stock Summary and Trading Ideas (Becton Dickinson And Company | NYSE:BDX)

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.

As of July 14, 2026, BDX stock price declined to $150.56 with 675,130 million shares trading.

BDX has a beta of 0.39, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.03 to the broad based SPY ETF.

BDX has a market cap of $42.83 billion. This is considered a Large Cap stock.

Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $2.90 earnings per share. This beat revenue expectation by $43 million and exceeded earnings estimates by $.13.

In the last 3 years, BDX traded as high as $287.32 and as low as $140.11.

The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

BDX has underperformed the market in the last year with a price return of +13.2% while the SPY ETF gained +21.6%. BDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.5% and -3.0%, respectively, while the SPY returned +9.7% and +1.4%, respectively.

BDX support price is $151.10 and resistance is $156.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.